因塞特医疗在2025年ASH大会上发布更新的积极数据,巩固了其首个靶向Mutcalr单克隆抗体Inca033989在原发性血小板增多症患者中的潜力

美股速递
Dec 09, 2025

因塞特医疗在2025年ASH大会上发布更新的积极数据,巩固了其首个靶向Mutcalr单克隆抗体Inca033989在原发性血小板增多症患者中的潜力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10